Hepatitis: Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases


    Related Conference of Hepatitis: Screening and Testing Methods

    July 25-26, 2024

    3rd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands

    Hepatitis: Screening and Testing Methods Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in